ArticleCureus2025

Partial Response to Sintilimab-Based Multimodal Therapy in a Refractory Primary Mediastinal Yolk Sac Tumor: A Case Report.

Yibo Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.